GAP

(Gemcitabine Abraxane Pancreas) trial

A PHASE II RANDOMIZED TRIAL COMPARING A COMBINATION OF ABRAXANE AND GEMCITABINE VERSUS GEMCITABINE ALONE AS FIRST LINE TREATMENT IN LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER

ESMO CONGRESS

BARCELLONA 27 SETTEMBRE - 1 OTTOBRE 2019

AIOM CONGRESS

ROMA 25 - 26 - 27 OTTOBRE 2019